98 reports

The 2019-2024 Outlook for Eye and Ear Preparations Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Anti-Infective
  • Therapy
  • United States
  • Demand

The 2019-2024 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Anti-Infective
  • Therapy
  • United States
  • Demand

Case study ##: RRD International & Dipexium Pharmaceuticals ##. ##. b.

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Demand
  • ANTI-INFECTIVES - YEAR-OVER-YEAR GROWTH 2018-2022 (%)
  • 48.17% of the market share comes from oncology

ONCOLOGY CARDIOVASCULAR ANTI-INFECTIVES......

  • Anti-Infective
  • United States
  • GlaxoSmithKline plc
  • PharmaMar SA
  • Seattle Genetics, Inc.
  • 12.4.6 KEY DEVELOPMENTS
  • 12. COMPANY PROFILES

As per data published by public sources, till mid of April, the Europe had an estimated ## million infected patients in the region.

  • Anti-Infective
  • United States
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.

Anti-infective Agents Market Size, Share & Trend Analysis By Type, By Route of Administration, By Distribution Channel And Segment Forecasts, 2019 - 2026 Chapter ##.

  • Anti-Infective
  • OTC
  • Pharmaceutical
  • Therapy
  • United States

Hoffmann-La Roche Ltd. ##. ## Boehringer Ingelheim GmbH List of Tables Table ## Global Anti-Infectives Market By Region, Market Forecast (2013-2025) (US $MN) Table ## Global Anti-Infectives Market By Antibacterials, Market Forecast (2013-2025) (US $MN) Table

  • Anti-Infective
  • Therapy
  • United States
  • Forecast
  • Market Size

Global Veterinary Anti-infectives Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## Strategic Benchmarking ##. ## Opportunity Analysis ## Exec

  • Anti-Infective
  • Veterinary Drug
  • United States
  • Forecast
  • Market Size
  • ZOETIS INC.
  • MERCK & CO.,

The company also launched Permacyl® an anti-infective for the treatment of mastitis among dairy cows.

  • Anti-Infective
  • United States
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Dechra Pharmaceuticals PLC
  • SHARE OF U.S. SALES OF PET MEDICATIONS BY TYPE, 2017

The Zymox products are antifungal, anti-yeast, and partially antibacterial, and according to the company, the products " thrive on dirty ears. "

  • Anti-Infective
  • United States
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merck & Co., Inc.

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Demand
  • 12.1 BIBLIOGRAPHY

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY; ##(##): ##-##.

  • Anti-Infective
  • United States
  • Achaogen, Inc.
  • Merck & Co., Inc.
  • The Medicines Company

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Demand
  • MARKET SHARE ANALYSIS 2014
  • OTHER PROMINENT VENDORS

The anti-infective pipeline products included are MK- ##A, MK-##, and MK-##.

  • Anti-Infective
  • United States
  • Allergan plc
  • Bayer AG
  • Merck & Co., Inc.

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand
  • MARKET SHARE ANALYSIS 2014
  • TEVA PHARMACEUTICALS

The anti-infective sales amounted to $## million in 2014.

  • Anti-Infective
  • United States
  • Allergan plc
  • Merck & Co., Inc.
  • Pfizer Inc.

(Hong Kong) ##.

  • Anti-Infective
  • Insulin
  • Therapy
  • United States
  • World
  • Vendor landscape

It is a multiple dose anti-infective steroid combination in the form of sterile suspension for topical application.

  • Anti-Infective
  • United States
  • Akorn, Inc.
  • Alcon, Inc.
  • Bausch & Lomb Incorporated

(India) ##.

  • Anti-Infective
  • United States
  • Demand
  • Market Shares
  • Market Size

" I use anti-infective therapies for general chronic therapy and most frequently [use] TOBI, just because it has been around the longest and it is the most experienced drug.

  • Anti-Infective
  • United States
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
  • system (and does not attempt to kill the bacteria directly), it is particularly relevant for antibioticresistant bacteria.
  • FEATURED NEWS & PRESS RELEASES

Dusquetide is an Innate Defense Regulator (IDR), which enhances the anti-infective activity of the innate immune system while down-modulating inflammation.

  • Anti-Infective
  • Infectious Disease
  • United States
  • Product Initiative
  • Soligenix, Inc.
  • 08/03/2017: MATINAS BIOPHARMA TO PROVIDE UPDATE ON ANTI-INFECTIVE PRODUCT CANDIDATE MAT2501 AT CANACCORD GENUITY 37TH ANNUAL GROWTH CONFERENCE
  • MAR 06, 2017: MATINAS BIOPHARMA AND NIH/NIAID INITIATE OPEN-LABEL EXTENSION TO PHASE 2A STUDY OF MAT2203 IN CHRONIC MUCOCUTANEOUS CANDIDIASIS

One group was infected as above and the other group was left un-infected.

  • Anti-Infective
  • Biopharmaceutical
  • United States
  • Company
  • Matinas BioPharma Holdings, Inc.
  • SEP 18, 2018: XELLIA PHARMACEUTICALS OPENS NORTH AMERICAN COMMERCIAL OFFICE IN CHICAGO AHEAD OF LAUNCHING VALUE-ADDED ANTI-INFECTIVE INJECTABLE DRUG PRODUCTS

Xellia has a long heritage in producing anti-infectives.

  • Anti-Infective
  • Pharmaceutical
  • United States
  • Company Operations
  • Deals & Alliance
  • CANTAB ANTI-INFECTIVES LTD
  • HB-1345 - DRUG PROFILE

DUSTIN WILLIAMS WHICH REPRESENTS TWO ANTI-INFECTIVE PROGRAMS AND ONE ONCOLOGY PROGRAM.

  • Anti-Infective
  • Antibiotic Resistance
  • Healthcare
  • Therapy
  • United States
  • Sandoz
  • Market share analysis 2014

The anti-infective sales amounted to $## million in 2014.

  • Anti-Infective
  • United States
  • Allergan plc
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company

Eisai' s major products include Pariet/ AcipHex (proton pump inhibitor); Aricept, an anti-Alzheimer' s agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others.

  • Anti-Infective
  • Blood Disease
  • United States
  • Product Initiative
  • AbbVie Inc.